Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07802210

Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease

Conditions: Sickle Cell Anemia in Children

Sex: All
Ages: 11 Years – 18 Years
Healthy volunteers: No
Phase: NA
Enrollment: 120
Sponsor: Aula Ibrahim abd alrazak

Location: Pediatric Hematology Center - Ibn Al-Baladi Maternity & Children Hospital and Hereditary Blood Diseases Center, Al-Karamah Teaching Hospital, Baghdad government. Baghdad Baghdad Governorate

Summary

Sickle-cell disease (SCD) is a genetic disorder that affects hemoglobin, the molecule in red blood cells responsible for carrying oxygen. The disease causes red blood cells to become rigid and sickle-shaped, leading to blockages in blood flow and subsequent pain and organ damage (World Health Organization (WHO),2025). Patients with sickle cell disease suffer from various complications of the disease during their lifetime, including anemia, sickle cell crises, acute chest syndrome, stroke, renal failure, retinal detachment and priapism. However, unforeseen and chronic pain crisis are the most common symptoms reported by the patients which are considered as the most common causes of referral to the emergency department and hospital to receive medical care in sickle cell patients (Poku, Atkin,\& Kirk,.2023). Objective(s) of the study: 1. To evaluate the effectiveness of Innovative Educational Methods on self-efficacy in children with sickle cell anemia. 2. To evaluate the effectiveness of Innovative Educational Methods on self-care capacity in children with sickle cell anemia. 3. To find out the relationship between the effectiveness of Innovative Educational Methods on self-efficacy, self-care capacity and demographic characteristics of children with sickle cell anemia.

Eligibility Criteria

Inclusion Criteria: 1. children with sickle cell anemia and visited Ibn Al-Baladi ,Al-Karamah center for hereditary blood diseases 2. age 12-18 years 3. being able to read and write 4. agrees and willing to participate in the study Exclusion Criteria: 1. children who have a history of mental illness 2. children with advanced complications of SCD, such as multi-system organ damage

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07802210). StuddyBuddy aggregates publicly available trial information.